Table 1 Relative mRNA abundance of selected differentially expressed genes in mammary parenchyma of late-pregnant gilts treated or not with domperidone

 ACKR2

0.19 (0.03)^b

0.28 (0.04)^b

3.08 (0.52)^a

<  0.001

 ANPEP

0.37 (0.04)^b

0.34 (0.03)^b

2.56 (0.45)^a

<  0.001

 BHLHE40

0.49 (0.08)^b

0.46 (0.04)^b

2.14 (0.20)^a

<  0.001

 CD14

0.27 (0.06)^b

0.38 (0.05)^b

2.20 (0.27)^a

<  0.001

 CD36

0.56 (0.05)^b

0.45 (0.05)^b

2.12 (0.28)^a

<  0.001

 CEBPD

0.41 (0.06)^b

0.43 (0.05)^b

2.32 (0.35)^a

<  0.001

 CIDEA

0.13 (0.03)^b

0.11 (0.02)^b

3.25 (0.80)^a

0.003

 ECM1

0.35 (0.06)^b

0.37 (0.04)^b

2.32 (0.23)^a

<  0.001

 EGF

0.22 (0.05)^b

0.26 (0.04)^b

2.92 (0.39)^a

<  0.001

 LALBA

0.12 (0.03)^b

0.14 (0.03)^b

2.60 (0.49)^a

<  0.001

 LRG1

0.14 (0.03)^b

0.18 (0.04)^b

2.52 (0.36)^a

<  0.001

 SPP1

0.24 (0.09)^b

0.33 (0.07)^b

2.39 (0.44)^a

<  0.001

 TC2N

0.54 (0.06)^b

0.61 (0.05)^b

1.89 (0.14)^a

<  0.001

 CAMK1G

1.64 (0.20)^a

0.98 (0.10)^b

0.27 (0.08)^c

<  0.001

 CHODL

1.18 (0.13)^a

1.11 (0.13)^a

0.21 (0.05)^b

<  0.001

 COL9A1

2.29 (0.45)^a

0.49 (0.14)^b

0.15 (0.04)^c

<  0.001

 CXCR4

0.98 (0.07)^a

1.08 (0.06)^a

0.52 (0.06)^b

<  0.001

 ERBB4

1.17 (0.14)^a

0.92 (0.10)^a

0.54 (0.09)^b

0.001

 FMO2

1.34 (0.19)^a

0.97 (0.18)^a

0.30 (0.04)^b

<  0.001

 NCALD

1.19 (0.07)^a

1.08 (0.09)^a

0.56 (0.06)^b

<  0.001

 P2RX7

1.41 (0.12)^a

0.88 (0.11)^b

0.44 (0.07)^c

<  0.001

 RCBTB1

1.27 (0.09)^a

1.08 (0.09)^a

0.54 (0.09)^b

<  0.001

 RGS2

1.21 (0.14)^a

1.11 (0.10)^a

0.44 (0.04)^b

<  0.001

 SCRG1

1.37 (0.18)^a

0.99 (0.09)^a

0.34 (0.06)^b

<  0.001

 SHC4

1.08 (0.09)^a

1.09 (0.08)^a

0.73 (0.09)^b

0.009

 TDRD1

1.44 (0.14) ^a

1.05 (0.09)^b

0.19 (0.05)^c

<  0.001